CN111358769A - Antimicrobial kits and articles - Google Patents
Antimicrobial kits and articles Download PDFInfo
- Publication number
- CN111358769A CN111358769A CN201811589716.4A CN201811589716A CN111358769A CN 111358769 A CN111358769 A CN 111358769A CN 201811589716 A CN201811589716 A CN 201811589716A CN 111358769 A CN111358769 A CN 111358769A
- Authority
- CN
- China
- Prior art keywords
- antimicrobial
- fabric carrier
- antimicrobial agent
- fabric
- per square
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 87
- 239000004744 fabric Substances 0.000 claims abstract description 106
- 239000004599 antimicrobial Substances 0.000 claims abstract description 104
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims abstract description 49
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims abstract description 49
- 239000007864 aqueous solution Substances 0.000 claims description 21
- 210000002414 leg Anatomy 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- -1 polyethylene Polymers 0.000 claims description 15
- 239000000969 carrier Substances 0.000 claims description 13
- 239000004698 Polyethylene Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 229920000728 polyester Polymers 0.000 claims description 12
- 229920000573 polyethylene Polymers 0.000 claims description 12
- 239000000835 fiber Substances 0.000 claims description 11
- 210000001217 buttock Anatomy 0.000 claims description 10
- 238000011200 topical administration Methods 0.000 claims description 9
- 210000001015 abdomen Anatomy 0.000 claims description 8
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 7
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 7
- 229920000297 Rayon Polymers 0.000 claims description 5
- 239000002964 rayon Substances 0.000 claims description 5
- 238000003287 bathing Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000035876 healing Effects 0.000 claims description 2
- 230000000813 microbial effect Effects 0.000 claims description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims 1
- 235000012208 gluconic acid Nutrition 0.000 claims 1
- 239000000174 gluconic acid Substances 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 8
- 206010072170 Skin wound Diseases 0.000 abstract 1
- 239000000047 product Substances 0.000 description 19
- 238000004659 sterilization and disinfection Methods 0.000 description 10
- 230000007774 longterm Effects 0.000 description 7
- 239000004745 nonwoven fabric Substances 0.000 description 5
- 206010011409 Cross infection Diseases 0.000 description 4
- 206010029803 Nosocomial infection Diseases 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 208000031650 Surgical Wound Infection Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000012864 cross contamination Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
提供一种抗微生物套组,包含抗微生物剂以及织物载体。抗微生物剂包含葡萄糖酸氯己定,织物载体每平方厘米可承载抗微生物剂0.025毫升至0.075毫升,以局部给予皮肤每平方厘米0.1至1.25毫克的葡萄糖酸氯己定。其中,织物载体不预先承载抗微生物剂。另提供一种抗微生物用品,包含织物载体。织物载体每平方厘米承载0.025毫升至0.075毫升的抗微生物剂,抗微生物剂包含葡萄糖酸氯己定,其中,织物载体用以局部给予皮肤每平方厘米0.1至1.25毫克的葡萄糖酸氯己定,以实现降低皮肤伤口感染且适量使用抗微生物剂的效果。
Provided is an antimicrobial kit, comprising an antimicrobial agent and a fabric carrier. The antimicrobial agent comprises chlorhexidine gluconate, and the fabric carrier can carry 0.025 ml to 0.075 ml of the antimicrobial agent per square centimeter, so as to topically administer 0.1 to 1.25 mg of chlorhexidine gluconate per square centimeter to the skin. The fabric carrier does not carry the antimicrobial agent in advance. Also provided is an antimicrobial product, comprising a fabric carrier. The fabric carrier carries 0.025 ml to 0.075 ml of the antimicrobial agent per square centimeter, and the antimicrobial agent comprises chlorhexidine gluconate, wherein the fabric carrier is used to topically administer 0.1 to 1.25 mg of chlorhexidine gluconate per square centimeter to the skin, so as to achieve the effect of reducing skin wound infection and using the antimicrobial agent in an appropriate amount.
Description
技术领域technical field
本发明涉及一种抗微生物套组及用品,且特别涉及一种具有抗微生物剂与织物载体的抗微生物套组及用品。The present invention relates to an antimicrobial kit and article, and in particular to an antimicrobial kit and article having an antimicrobial agent and a fabric carrier.
背景技术Background technique
医疗感染是全球疾病管理的重大议题。手术部位感染,除了会造成医疗费用增加、住院天数延长之外,还会升高病患发生败血症及死亡的风险。“推动组合式照护措施降低手术部位感染先驱研究计划”2016年研究报告指出,术前沐浴措施的执行率偏低。人体皮肤上固定存在着多种微生物,其为皮肤表面产生伤口时发生感染的主要来源。如果皮肤表面消毒不完全,皮肤表皮细胞层的微生物会经由医疗手术、侵入性医疗处置或伤口处理进入体内,造成医疗感染。因此,提高术前沐浴的执行率及加强术前皮肤准备,应为有效降低手术部位感染率的方式之一。Healthcare infections are a major issue in global disease management. Surgical site infections, in addition to increasing medical costs and length of hospital stay, increase the risk of sepsis and death in patients. A 2016 study by the Pioneer Research Initiative on Advancing Combined Care Measures to Reduce Surgical Site Infections noted that preoperative bathing measures are underperforming. A variety of microorganisms are fixed on human skin, which are the main source of infection when wounds occur on the skin surface. If the skin surface is not completely disinfected, microorganisms in the epidermal cell layer of the skin can enter the body through medical surgery, invasive medical treatment or wound treatment, causing medical infection. Therefore, improving the execution rate of preoperative bathing and strengthening preoperative skin preparation should be one of the ways to effectively reduce the infection rate of the surgical site.
近年来,随着人口迈向高龄化,以及罹患特殊疾病例如艾滋病、尿毒症、创伤后遗症等而需要特殊护理或长期照护的病患越来越多,对于特殊护理或长期照护机构的感染控制要求升高,同时对机构内感染管制的执行作业也有越来越多的关注。特别是需要长期照护的年长者及病患身体较虚弱,在机构内发生皮肤接触性传染病和呼吸道传染病“群聚感染”事件的风险较高,因此需加强机构内感染的监测、感染管制防护措施及照顾者的知识能力相当重要。In recent years, with the aging of the population, and more and more patients suffering from special diseases such as AIDS, uremia, post-traumatic sequelae, etc. requiring special care or long-term care, the infection control requirements for special care or long-term care institutions There is also growing concern about the enforcement of infection control in institutions. In particular, the elderly and patients who need long-term care are relatively weak, and the risk of "cluster infections" of skin-to-skin infectious diseases and respiratory infectious diseases in institutions is high. Controlling protective measures and the knowledge of caregivers are important.
此外,医护人员在进行临床医疗措施时,特别是紧急医疗措施,如在救护车上或急诊内为患者皮肤进行消毒时,常直接将棉棒、纱布巾浸入消毒剂瓶罐内,再于皮肤表面进行擦拭消毒。然而,在紧急状态下瓶罐操作起来较不便捷,且容易产生交叉感染,在完成消毒作业后余下的消毒剂恐无法再次使用,也造成资源的浪费。In addition, when medical staff perform clinical medical measures, especially emergency medical measures, such as disinfecting the skin of patients in ambulances or in emergency rooms, they often directly dip cotton swabs and gauze towels into disinfectant bottles, and then apply them to the skin. Wipe and disinfect surfaces. However, it is inconvenient to operate bottles and cans in an emergency, and cross-infection is likely to occur. After the disinfection operation is completed, the remaining disinfectant may not be used again, which also results in a waste of resources.
有鉴于此,如何减少实施侵入性医疗处置后发生感染的风险、加强临床医疗紧急措施以及长期照护机构内的感染管制,同时有效、适量且方便地使用消毒剂,现有技术实有待改善的必要。In view of this, how to reduce the risk of infection after invasive medical treatment, strengthen clinical medical emergency measures and infection control in long-term care facilities, and at the same time use disinfectants effectively, appropriately and conveniently, the existing technology needs to be improved. .
发明内容SUMMARY OF THE INVENTION
为了解决现有技术中所述的问题,本公开内容的目的在于提供一种抗微生物套组及一种抗微生物用品,以实现降低实施侵入性医疗处置后发生感染的风险、加强临床医疗紧急措施以及长期照护机构内的感染管制,且方便使用者有效并适量使用抗微生物剂的效果。In order to solve the problems described in the prior art, the purpose of the present disclosure is to provide an anti-microbial kit and an anti-microbial product, so as to reduce the risk of infection after invasive medical treatment and strengthen emergency clinical measures As well as infection control in long-term care facilities, and the effect of user-friendly effective and appropriate use of antimicrobials.
本公开内容提供了一种抗微生物套组,包含抗微生物剂以及织物载体。抗微生物剂包含葡萄糖酸氯己定(chlorhexidine gluconate,CHG),织物载体每平方厘米可承载抗微生物剂0.025毫升至0.075毫升(mL/cm2),以局部给予(topical administration)皮肤每平方厘米0.1至1.25毫克的葡萄糖酸氯己定,且织物载体不预先承载抗微生物剂。The present disclosure provides an antimicrobial kit comprising an antimicrobial agent and a fabric carrier. The antimicrobial agent includes chlorhexidine gluconate (CHG), the fabric carrier can carry 0.025 milliliters to 0.075 milliliters (mL/cm 2 ) of the antimicrobial agent per square centimeter, for topical administration (0.1 per square centimeter of the skin) to 1.25 mg of chlorhexidine gluconate, and the fabric carrier was not preloaded with an antimicrobial agent.
在一些实施方式中,抗微生物剂是重量体积百分比为0.1%至10%(w/v%)的葡萄糖酸氯己定水溶液。In some embodiments, the antimicrobial agent is 0.1% to 10% (w/v%) by weight volume percent of chlorhexidine gluconate in water.
在一些实施方式中,抗微生物剂被包装于一容器中,容器的材质包含但不限于聚乙烯(polyethylene,PE)、聚对苯二甲酸乙二醇酯(Polyethylene Terephthalate,PET)或其组合。In some embodiments, the antimicrobial agent is packaged in a container, and the material of the container includes, but is not limited to, polyethylene (PE), polyethylene terephthalate (PET), or a combination thereof.
在一些实施方式中,织物载体具有多孔网状结构。In some embodiments, the fabric support has a porous network structure.
在一些实施方式中,织物载体的厚度为每平方米30克至100克(g/m2)。在一些实施例中,织物载体厚度为95g/m2。In some embodiments, the fabric support has a thickness of 30 grams to 100 grams per square meter (g/m 2 ). In some embodiments, the fabric support has a thickness of 95 g/m 2 .
在一些实施方式中,织物载体呈正方形或长方形。In some embodiments, the fabric carrier is square or rectangular.
在一些实施方式中,其中织物载体可将承载的抗微生物剂无残留地释出至皮肤上。In some embodiments, wherein the fabric carrier can release the loaded antimicrobial agent to the skin without residue.
在一些实施方式中,织物载体的材质包含,但不限于聚酯纤维、缧萦或其组合。In some embodiments, the material of the fabric carrier includes, but is not limited to, polyester fiber, rayon, or a combination thereof.
在一些实施方式中,织物载体的材质为百分之百聚酯纤维,每平方厘米可承载0.045至0.065毫升(mL/cm2)的抗微生物剂。In some embodiments, the fabric carrier is made of 100% polyester fiber and can carry 0.045 to 0.065 milliliters (mL/cm 2 ) of antimicrobial agent per square centimeter.
本公开内容另提供了一种抗微生物用品,包含织物载体,织物载体每平方厘米承载0.025毫升至0.075毫升的抗微生物剂,抗微生物剂包含葡萄糖酸氯己定。其中,织物载体用以局部给予皮肤每平方厘米0.1至1.25毫克的葡萄糖酸氯己定。The present disclosure further provides an antimicrobial product comprising a fabric carrier that carries 0.025 ml to 0.075 ml of an antimicrobial agent per square centimeter, the antimicrobial agent comprising chlorhexidine gluconate. Among them, the fabric carrier is used for topical administration of 0.1 to 1.25 mg of chlorhexidine gluconate per square centimeter to the skin.
在一些实施方式中,抗微生物用品被包装于一容器中,容器的材质包含但不限于聚乙烯、聚对苯二甲酸乙二醇酯或其组合。In some embodiments, the antimicrobial product is packaged in a container comprising, but not limited to, polyethylene, polyethylene terephthalate, or a combination thereof.
本公开内容另提供了一种抗微生物用品,包含多个织物载体,各织物载体每平方厘米承载0.025毫升至0.075毫升的抗微生物剂,抗微生物剂包含葡萄糖酸氯己定。其中,各织物载体用以局部给予皮肤每平方厘米0.1至1.25毫克的葡萄糖酸氯己定。The present disclosure further provides an antimicrobial product comprising a plurality of fabric carriers, each fabric carrier carrying 0.025 ml to 0.075 ml of an antimicrobial agent per square centimeter, the antimicrobial agent comprising chlorhexidine gluconate. Wherein, each fabric carrier is used for topical administration of 0.1 to 1.25 mg of chlorhexidine gluconate per square centimeter to the skin.
在一些实施方式中,各织物载体承载30毫升的抗微生物剂,且抗微生物剂为重量体积百分比2%的葡萄糖酸氯己定水溶液。In some embodiments, each fabric carrier carries 30 milliliters of antimicrobial agent, and the antimicrobial agent is a 2% by weight aqueous solution of chlorhexidine gluconate.
在一些实施方式中,这些织物载体的数量为8个,且包装于一容器中,容器的材质为聚乙烯。In some embodiments, the number of these fabric carriers is 8, and they are packaged in a container, and the material of the container is polyethylene.
本公开内容另提供了一种抗微生物用品,包含至少一织物载体,至少一织物载体每平方厘米承载0.025毫升至0.075毫升的抗微生物剂,抗微生物剂包含葡萄糖酸氯己定,其中,至少一织物载体用以局部给予皮肤每平方厘米0.1至1.25毫克的葡萄糖酸氯己定。The present disclosure further provides an antimicrobial product, comprising at least one fabric carrier, and the at least one fabric carrier carries 0.025 ml to 0.075 ml of an antimicrobial agent per square centimeter, the antimicrobial agent comprising chlorhexidine gluconate, wherein at least one The fabric carrier is used for topical administration of 0.1 to 1.25 mg of chlorhexidine gluconate per square centimeter to the skin.
在一些实施方式中,其中,将至少一织物载体浸泡于抗微生物剂,使得浸泡后的至少一织物载体每平方厘米承载0.025毫升至0.075毫升的抗微生物剂。In some embodiments, the at least one fabric carrier is soaked in the antimicrobial agent, so that the soaked at least one fabric carrier carries 0.025 ml to 0.075 ml of the antimicrobial agent per square centimeter.
在一些实施方式中,织物载体的材质为聚酯纤维,每平方厘米承载0.045至0.065毫升的抗微生物剂。In some embodiments, the fabric carrier is made of polyester fibers and carries 0.045 to 0.065 milliliters of antimicrobial agent per square centimeter.
在一些实施方式中,包含八个织物载体,八个织物载体是分别用于肩颈部位、胸部、双臂至手掌、双腿前侧、下腹部、下颈部至后背、双腿后侧以及后腰间至臀部。In some embodiments, eight fabric carriers are included, and the eight fabric carriers are respectively used for the shoulder and neck, chest, arms to palms, front of legs, lower abdomen, lower neck to back, and back of legs Side and back waist to buttocks.
在一些实施方式中,八个织物载体用以按序用于肩颈部位、胸部、双臂至手掌、双腿前侧、下腹部、下颈部至后背、双腿后侧以及后腰间至臀部。In some embodiments, eight fabric carriers are used in sequence for the shoulder and neck area, chest, arms to palms, front of legs, lower abdomen, lower neck to back, back of legs, and back waist to the buttocks.
在一些实施方式中,抗微生物用品是在实施侵入性医疗处置前使用。In some embodiments, the antimicrobial device is used prior to performing invasive medical procedures.
在一些实施方式中,是在实施侵入性医疗处置前先进行沐浴,再使用抗微生物用品。In some embodiments, bathing is performed prior to invasive medical procedures, followed by the use of antimicrobial products.
在一些实施方式中,抗微生物用品是在实施侵入性医疗处置当日及前三日每日使用一次。In some embodiments, the antimicrobial device is used once daily on the day and three days preceding the invasive medical procedure.
在一些实施方式中,抗微生物用品是在实施侵入性医疗处置后每日使用至接受侵入性医疗处置处愈合。In some embodiments, the antimicrobial device is used daily after the invasive medical treatment until healing at the site receiving the invasive medical treatment.
承上所述,本公开内容的抗微生物套组及抗微生物用品皆包括含有葡萄糖酸氯己定的抗微生物剂以及织物载体。本公开内容的抗微生物套组及抗微生物用品,由于织物载体可以擦拭的面积较大,故在使用上更加便利,且可适量使用抗微生物剂,同时仍能达到消毒的有效量。在一些实施例中,抗微生物套组或抗微生物用品包含八个织物载体,可分别用于肩颈部位、胸部、双臂至手掌、双腿前侧、下腹部、下颈部至后背、双腿后侧以及后腰间至臀部,避免交互污染,落实消毒效果。若将抗微生物套组及抗微生物用品使用于接受侵入性医疗处置的病患,可降低实施侵入性医疗处置后发生感染的风险;若使用于特殊照护机构或长期照护机构内的患者,则可降低机构内感染的风险,以加强机构内的感染管制;若在施行临床医疗措施时使用,则可方便使用者有效并适量使用抗微生物剂。As mentioned above, the antimicrobial kits and antimicrobial articles of the present disclosure all include an antimicrobial agent containing chlorhexidine gluconate and a fabric carrier. The antimicrobial kit and antimicrobial product of the present disclosure are more convenient to use because the fabric carrier can wipe a larger area, and an appropriate amount of antimicrobial agent can be used while still achieving an effective amount for disinfection. In some embodiments, the antimicrobial kit or article includes eight fabric carriers for use on the shoulder and neck, chest, arms to palms, front of legs, lower abdomen, lower neck to back , the back of the legs and the back waist to the buttocks to avoid cross-contamination and implement the disinfection effect. Antimicrobial kits and supplies can reduce the risk of infection after invasive medical procedures when used on patients undergoing invasive medical procedures; To reduce the risk of infection in the facility to strengthen infection control in the facility; if used in clinical practice, it can facilitate the effective and appropriate use of antimicrobials by the user.
附图说明Description of drawings
图1示出本公开内容的织物载体在人体正面皮肤擦拭区域的示意图。FIG. 1 shows a schematic diagram of the fabric carrier of the present disclosure in the wiping area of the frontal skin of a human body.
图2示出本公开内容的织物载体在人体背面皮肤擦拭区域的示意图。FIG. 2 shows a schematic diagram of the wiping area of the skin on the back of the human body by the fabric carrier of the present disclosure.
附图标记说明Description of reference numerals
10肩颈部位10 shoulder and neck
20胸部20 boobs
30双臂至手掌30 Arms to Palms
40双腿前侧40 front legs
50下腹部50 lower abdomen
60下颈部至后背60 lower neck to back
70双腿后侧70 back of legs
80后腰间至臀部。After 80, from the waist to the buttocks.
具体实施方式Detailed ways
本发明上述和其它实施方式、特征及其它优点参照说明书内容并配合附加附图得到更清楚的了解。The above and other embodiments, features and other advantages of the present invention will be more clearly understood with reference to the description in conjunction with the accompanying drawings.
为了使本公开内容的叙述更加详尽与完备,下文将参照附图来描述本发明的实施方式与具体实施例;但这并非实施或运用本公开内容具体实施例的唯一形式。以下所公开的各实施例,在有益的情形下可相互组合或取代,也可在一实施例中附加其它的实施例,而无须进一步的记载或说明。In order to make the description of the present disclosure more detailed and complete, the embodiments and specific embodiments of the present disclosure will be described below with reference to the accompanying drawings; but this is not the only form of implementing or using the specific embodiments of the present disclosure. The embodiments disclosed below can be combined or substituted with each other under beneficial circumstances, and other embodiments can also be added to one embodiment without further description or explanation.
本文中所使用的“包含”、“包括”、“具有”及相似词汇,指明其所记载的特征、区域、整数、步骤、操作、组件和/或组件,但不排除其它的特征、区域、整数、步骤、操作、组件、组件,和/或其中的群组。As used herein, "comprises", "includes", "has" and similar words designate its recited features, regions, integers, steps, operations, components and/or components, but do not exclude other features, regions, Integers, steps, operations, components, components, and/or groups thereof.
本文中,术语“容器”在文中表示包含但不限于固定形状、非固定形状,例如如袋体、罐体、瓶体或管体。As used herein, the term "container" is meant herein to include, but is not limited to, fixed shapes, non-fixed shapes such as, for example, bags, cans, bottles, or tubes.
本发明各种实施方式的抗微生物套组包含抗微生物剂与织物载体。抗微生物剂包含葡萄糖酸氯己定,可为重量体积百分比0.1%至10%(w/v)的葡萄糖酸氯己定水溶液,优选为1.6%至2.4%(w/v)的葡萄糖酸氯己定水溶液,优选为2%(w/v)的葡萄糖酸氯己定水溶液。The antimicrobial kits of various embodiments of the present invention comprise an antimicrobial agent and a fabric carrier. The antimicrobial agent comprises chlorhexidine gluconate, which can be a 0.1% to 10% (w/v) aqueous solution of chlorhexidine gluconate, preferably 1.6% to 2.4% (w/v) chlorhexidine gluconate An aqueous solution, preferably a 2% (w/v) aqueous solution of chlorhexidine gluconate.
织物载体具有多孔网状结构,多孔网状结构的孔隙可吸附抗微生物剂,借此有效承载并携带抗微生物剂,且在使用时可将织物载体所承载的抗微生物剂完全释出。以面积为600平方厘米的织物载体为例,可承载15至45毫升的抗微生物剂,即每平方厘米织物载体可承载抗微生物剂0.025毫升至0.075毫升,优选为0.045毫升至0.065毫升,优选为0.05毫升,以局部给予皮肤每平方厘米0.1至1.25毫克的葡萄糖酸氯己定。织物载体的厚度为30g/m2至100g/m2,优选为95g/m2。若织物载体所承载的葡萄糖酸氯己定水溶液低于0.025mL/cm2,释放至皮肤表面的葡萄糖酸氯己定水溶液不足以达到消毒的效果;0.075mL/cm2则是织物载体所能承载的葡萄糖酸氯己定水溶液上限,超过上限葡萄糖酸氯己定水溶液会滴落,增加操作难度。The fabric carrier has a porous network structure, and the pores of the porous network structure can adsorb the antimicrobial agent, thereby effectively carrying and carrying the antimicrobial agent, and the antimicrobial agent carried by the fabric carrier can be completely released during use. Taking a fabric carrier with an area of 600 square centimeters as an example, it can carry 15 to 45 milliliters of antimicrobial agent, that is, each square centimeter of the fabric carrier can carry 0.025 milliliters to 0.075 milliliters of antimicrobial agents, preferably 0.045 milliliters to 0.065 milliliters, preferably 0.045 milliliters to 0.065 milliliters. 0.05 ml, 0.1 to 1.25 mg of chlorhexidine gluconate per square centimeter for topical administration to the skin. The thickness of the fabric support is 30 g/m 2 to 100 g/m 2 , preferably 95 g/m 2 . If the chlorhexidine gluconate aqueous solution carried by the fabric carrier is less than 0.025mL/cm 2 , the chlorhexidine gluconate aqueous solution released to the skin surface is not enough to achieve the effect of disinfection; 0.075mL/cm 2 is the amount that the fabric carrier can carry. The upper limit of the chlorhexidine gluconate aqueous solution exceeds the upper limit, and the chlorhexidine gluconate aqueous solution will drip and increase the difficulty of operation.
在一实施例中,织物载体的尺寸为20×30厘米,可承载30毫升的抗微生物剂,其中抗生物剂为2%(w/v)的葡萄糖酸氯己定水溶液。依卫生福利部统计数据及体表面积计算公式:体表面积(平方米)=(体重(公斤)×身高(厘米)/3600)1/2,可计算出2岁至成年人的平均体表面积范围为5812平方厘米至18641平方厘米。若以8片织物载体擦拭全身皮肤,可计算出每片承载有600毫克葡萄糖酸氯己定的织物载体可局部给予每平方厘米皮肤0.25毫克至0.83毫克的抗微生物剂。In one embodiment, the size of the fabric carrier is 20×30 cm and can carry 30 milliliters of antimicrobial agent, wherein the antimicrobial agent is a 2% (w/v) aqueous solution of chlorhexidine gluconate. According to the statistics of the Ministry of Health and Welfare and the calculation formula of body surface area: body surface area (square meter) = (weight (kg) × height (cm)/3600) 1/2 , the average body surface area from 2 years old to adults can be calculated as: 5812 square centimeters to 18641 square centimeters. If 8 pieces of fabric carrier were wiped on the whole body skin, it was calculated that each piece of fabric carrier carrying 600 mg of chlorhexidine gluconate could deliver 0.25 mg to 0.83 mg of antimicrobial agent per square centimeter of skin topically.
织物载体具有可将承载的抗微生物剂无残留地释出至皮肤上的特性。在一些实施例中,织物载体的材质为百分之百聚酯纤维(Polyester)的不织布。在一些实施例中,织物载体的材质可为聚酯纤维及嫘萦(Rayon)所组成的不织布,例如由百分之五十聚酯纤维及百分之五十嫘萦混纺而成的不织布。本发明不限制织物载体的形状,织物载体优选可为矩形,包含正方形、长方形等形状。在一些实施例中,用于大面积擦拭时,织物载体可设计为长方形,例如20×30厘米,正方形的织物载体在大面积擦拭消毒时易于卷曲不利擦拭,而长方形的织物载体在大面积擦拭消毒时有不易于卷曲且易于施力的优点。The fabric carrier has the property of delivering the loaded antimicrobial agent to the skin without residue. In some embodiments, the material of the fabric carrier is a non-woven fabric of 100% polyester fiber (Polyester). In some embodiments, the material of the fabric carrier can be a non-woven fabric composed of polyester fibers and rayon, for example, a non-woven fabric that is blended with 50% polyester fiber and 50% rayon. The present invention does not limit the shape of the fabric carrier, and the fabric carrier may preferably be a rectangle, including a square, a rectangle, and the like. In some embodiments, when used for wiping a large area, the fabric carrier can be designed to be a rectangle, such as 20×30 cm. The square fabric carrier is easy to curl when wiping and disinfecting a large area, which is unfavorable for wiping, while the rectangular fabric carrier is used for wiping a large area. It has the advantages that it is not easy to curl and is easy to apply force when sterilizing.
本发明的织物载体具多孔网状结构与厚度,可于临床擦拭时保护皮肤不遭受过度物理性摩擦伤害。因此,在一优选的实施例中,抗微生物套组中的抗微生物剂为2%(w/v)葡萄糖酸氯己定水溶液,且抗微生物剂可以在无保湿润肤成分下也能维持舒适肤触。The fabric carrier of the present invention has a porous network structure and thickness, and can protect the skin from excessive physical friction damage during clinical wiping. Therefore, in a preferred embodiment, the antimicrobial agent in the antimicrobial kit is a 2% (w/v) aqueous solution of chlorhexidine gluconate, and the antimicrobial agent can maintain comfort without moisturizing skin ingredients skin touch.
抗微生物套组为组合式产品,织物载体与抗微生物剂分别在个别的分隔区内,并在相同或不同的包装中,使用时再将织物载体与抗微生物剂进行混和。抗微生物套组中织物载体的数量可以是一片织物载体、或是多个片织物载体。抗微生物套组中的抗微生物剂可容置于瓶体内,瓶体可选择不会与葡萄糖酸氯己定反应发生沉淀现象的材质,而不会影响抗微生物剂的技术效果。前述材质可例如为聚乙烯(polyethylene,PE)、聚对苯二甲酸乙二醇酯(Polyethylene Terephthalate,PET)或其组合。其中,聚乙烯可包含高密度聚乙烯及低密度聚乙烯。在一具体实施例中,抗微生物套组可包含容置于瓶体中的2%(w/v)葡萄糖酸氯己定水溶液以及容置于袋体的织物载体。使用时,将葡萄糖酸氯己定水溶液全部倒入袋体中,使织物载体浸润于葡萄糖酸氯己定水溶液中,待织物载体承载足量的葡萄糖酸氯己定水溶液后再取出使用。The antimicrobial kit is a combined product, the fabric carrier and the antimicrobial agent are in separate compartments, and in the same or different packaging, and the fabric carrier and the antimicrobial agent are mixed at the time of use. The number of fabric supports in the antimicrobial kit can be one piece of fabric support, or multiple pieces of fabric support. The antimicrobial agent in the antimicrobial kit can be contained in the bottle body, and the bottle body can be selected from a material that will not react with chlorhexidine gluconate and cause precipitation, without affecting the technical effect of the antimicrobial agent. The aforementioned material can be, for example, polyethylene (PE), polyethylene terephthalate (PET), or a combination thereof. Wherein, the polyethylene can include high density polyethylene and low density polyethylene. In a specific embodiment, the antimicrobial kit may comprise a 2% (w/v) aqueous solution of chlorhexidine gluconate contained in a bottle body and a fabric carrier contained in a bag body. When in use, pour all the chlorhexidine gluconate aqueous solution into the bag body, so that the fabric carrier is immersed in the chlorhexidine gluconate aqueous solution, and then take it out for use after the fabric carrier supports a sufficient amount of the chlorhexidine gluconate aqueous solution.
抗微生物用品包含抗微生物剂与织物载体,且为预先结合式产品,即织物载体预先承载抗微生物剂。其中抗微生物剂及织物载体与前述抗微生物套组的抗微生物剂及织物载体相同,在此不再赘述。The antimicrobial product comprises an antimicrobial agent and a fabric carrier, and is a pre-integrated product, that is, the fabric carrier is pre-loaded with the antimicrobial agent. The antimicrobial agent and the fabric carrier are the same as the antimicrobial agent and the fabric carrier of the aforementioned antimicrobial kit, which will not be repeated here.
在一具体实施例中,抗微生物用品的制作过程是先将20%(w/v)葡萄糖酸氯己定水溶液加入纯水稀释至2%(w/v),然后将2%(w/v)葡萄糖酸氯己定水溶液倒入装有至少一片不织布的袋体内,优选为8片不织布,封口后即获得抗微生物用品。其中,袋体的材质为聚乙烯,聚乙烯袋体除了密封性佳之外,与抗微生物剂长时间接触下不会与葡萄糖酸氯己定作用而使抗微生物剂发生沉淀,不影响抗微生物剂的功效。In a specific embodiment, the manufacturing process of the antimicrobial product is to add a 20% (w/v) aqueous solution of chlorhexidine gluconate to pure water to dilute to 2% (w/v), and then dilute the 2% (w/v) ) The aqueous solution of chlorhexidine gluconate is poured into the bag body containing at least one piece of non-woven fabric, preferably 8 pieces of non-woven fabric, and the antimicrobial product is obtained after sealing. Among them, the material of the bag body is polyethylene. In addition to good sealing performance, the polyethylene bag body will not act with chlorhexidine gluconate under long-term contact with the antimicrobial agent to cause the precipitation of the antimicrobial agent, and does not affect the antimicrobial agent. effect.
在一些实施例中,抗微生物套组或抗微生物用品可在实施侵入性医疗处置前施用于皮肤,以降低医疗感染风险。侵入性医疗处置可例如为:划刀切开手术、穿刺、插入导管或引流管等等。以划刀切开手术为例:患者于手术前三日至前一晚全身沐浴后,每日从抗微生物套组或抗微生物用品中取出以2%(w/v)葡萄糖酸氯己定水溶液充分浸润的织物载体擦拭全身;手术当天再次以抗微生物套组或抗微生物用品擦拭全身。侵入性医疗处置后,也可以抗微生物套组或抗微生物用品擦拭全身或接受侵入性医疗处置处,直至接受侵入性医疗处置处愈合。In some embodiments, antimicrobial kits or antimicrobial articles may be applied to the skin prior to invasive medical procedures to reduce the risk of medical infections. Invasive medical procedures may be, for example: stab incisions, puncture, insertion of catheters or drains, and the like. Take the incision surgery as an example: after taking a full body bath three days before the operation to the night before the patient, take out the 2% (w/v) chlorhexidine gluconate aqueous solution from the anti-microbial kit or anti-microbial supplies every day. Wipe the entire body with a fully soaked fabric carrier; wipe the entire body again on the day of surgery with the Antimicrobial Kit or Antimicrobial Supplies. After invasive medical treatment, the whole body or the invasive medical treatment can also be swabbed with an antimicrobial kit or anti-microbial product until the invasive medical treatment has healed.
在一实施例中,抗微生物套组或抗微生物用品可用于皮肤或器具的清洁及消毒,使用后无需再以水清洗。例如:加护病房的病患、长期照护的病患可每日以抗微生物套组或抗微生物用品擦拭全身,以降低院内感染的风险;接受侵入性医疗处置后的患者,也可以抗微生物套组或抗微生物用品擦拭全身或接受侵入性医疗处置的患部,以降低术后感染的风险;在进行临床医疗时,尤其是紧急状态下,例如在救护车上紧急以抗微生物套组或抗微生物用品用于患者皮肤的消毒,通过一包装具有多片含2%(w/v)葡萄糖酸氯己定水溶液浸渍的织物载体的组合,以达到使用方便、避免浪费抗微生物剂的效果;医疗器材如导管在实施侵入性医疗处置前,也可以抗微生物套组或抗微生物用品进行消毒。In one embodiment, the antimicrobial kit or the antimicrobial product can be used for cleaning and disinfecting the skin or utensils, and there is no need to wash with water after use. For example: patients in intensive care units and patients in long-term care can wipe their bodies with antimicrobial kits or antimicrobial products daily to reduce the risk of nosocomial infections; patients after invasive medical treatment can also use antimicrobial kits swabbing the whole body or affected area undergoing invasive medical treatment to reduce the risk of postoperative infection; in clinical medical care, especially in emergency situations, such as emergency use of antimicrobial kits or antimicrobials in ambulances The article is used for the disinfection of the patient's skin, and a package is provided with a combination of multiple pieces of fabric carrier impregnated with an aqueous solution of 2% (w/v) chlorhexidine gluconate, so as to achieve the effect of being convenient to use and avoiding the waste of antimicrobial agents; medical equipment For example, catheters can also be sterilized with antimicrobial kits or supplies prior to invasive medical procedures.
在一实施例中,抗微生物套组或抗微生物用品在使用时,是以承载有抗微生物剂的织物载体局部施予皮肤以消毒杀菌,且单张织物载体是分区单次使用以预防交互感染。例如:依据人体所需的消毒部位建立八步骤临床使用次序,按照此次序擦拭可避免交互感染,依照图1及图2将身体分为八区,分别为人体正面的肩颈部位10、胸部20、双臂至手掌30、双腿前侧40、下腹部50,人体背面的下颈部至后背60、双腿后侧70、后腰间至臀部80。其中,胸部20还可包含胸部及胸部周边部位,后腰间至臀部80包含腰间至双臀与大腿连接处的后侧。使用抗微生物套组或抗微生物用品时,依上述八个分区每区分别使用一片承载有抗微生物剂的织物载体擦拭需要清洁消毒的皮肤,并确保肌肤充分擦拭到抗微生物剂,待30秒钟使肌肤自然干燥即可。以微生物剂擦拭过后,肌肤会呈现光泽感,可依此判断肌肤已充分擦拭到抗微生物剂。在其它实施例中,抗微生物套组或抗微生物用品在使用时,也可单次使用单张承载有抗微生物剂的织物载体以施用于局部皮肤,并不限制于上述用法。In one embodiment, when the antimicrobial kit or the antimicrobial product is in use, a fabric carrier loaded with an antimicrobial agent is locally applied to the skin for disinfection and sterilization, and a single fabric carrier is used in a partitioned and single-use manner to prevent cross-infection . For example: establish an eight-step clinical use sequence according to the disinfection parts required by the human body, and wipe in this sequence to avoid cross-infection. According to Figure 1 and Figure 2, the body is divided into eight areas, which are the shoulders and neck parts of the front of the
承上所述,本公开内容的抗微生物套组及抗微生物用品皆包括含有葡萄糖酸氯己定的抗微生物剂以及织物载体。本公开内容的抗微生物套组及抗微生物用品,由于织物载体可以擦拭的面积较大,故在使用上更加便利,且可适量使用抗微生物剂,同时仍能达到消毒的有效量。在一些实施例中,抗微生物套组或抗微生物用品包含八个织物载体,可分别用于肩颈部位、胸部、双臂至手掌、双腿前侧、下腹部、下颈部至后背、双腿后侧以及后腰间至臀部,避免交互污染,落实消毒效果。若将抗微生物套组及抗微生物用品使用于接受侵入性医疗处置的病患,可降低实施侵入性医疗处置后发生感染的风险;若使用于特殊照护机构或长期照护机构内的患者,则可降低机构内感染的风险,以加强机构内的感染管制;若在施行临床医疗措施时使用,则可方便使用者有效并适量使用抗微生物剂。As mentioned above, the antimicrobial kits and antimicrobial articles of the present disclosure all include an antimicrobial agent containing chlorhexidine gluconate and a fabric carrier. The antimicrobial kit and antimicrobial product of the present disclosure are more convenient to use because the fabric carrier can wipe a larger area, and an appropriate amount of antimicrobial agent can be used while still achieving an effective amount for disinfection. In some embodiments, the antimicrobial kit or article includes eight fabric carriers for use on the shoulder and neck, chest, arms to palms, front of legs, lower abdomen, lower neck to back , the back of the legs and the back waist to the buttocks to avoid cross-contamination and implement the disinfection effect. Antimicrobial kits and supplies can reduce the risk of infection after invasive medical procedures when used on patients undergoing invasive medical procedures; To reduce the risk of infection in the facility to strengthen infection control in the facility; if used in clinical practice, it can facilitate the effective and appropriate use of antimicrobials by the user.
虽然本发明已以实施方式公开如上,然其并非用以限定本发明,任何本领域技术人员,在不脱离本发明的构思和范围内,当可作各种的变形与修饰,因此本发明的保护范围当视权利要求所界定者为准。Although the present invention has been disclosed in the above embodiments, it is not intended to limit the present invention. Any person skilled in the art can make various changes and modifications without departing from the spirit and scope of the present invention. The scope of protection shall be determined by the claims.
Claims (25)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811589716.4A CN111358769A (en) | 2018-12-25 | 2018-12-25 | Antimicrobial kits and articles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811589716.4A CN111358769A (en) | 2018-12-25 | 2018-12-25 | Antimicrobial kits and articles |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111358769A true CN111358769A (en) | 2020-07-03 |
Family
ID=71198133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811589716.4A Pending CN111358769A (en) | 2018-12-25 | 2018-12-25 | Antimicrobial kits and articles |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111358769A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5690958A (en) * | 1996-09-30 | 1997-11-25 | Medi-Flex Hospital Products, Inc. | Unit dose chlorhexadine gluconate(CHG) applicator having extended CHG shelf life |
CN2327337Y (en) * | 1998-02-17 | 1999-07-07 | 赵清玲 | Disposable assembled box for sterilization and dressing change |
US20040230168A1 (en) * | 2003-05-12 | 2004-11-18 | Thomas Keaty | Disinfectant delivery system, and method of providing alcohol-free disinfection |
CN103704241A (en) * | 2013-12-23 | 2014-04-09 | 杭州美克恒辉实业有限公司 | Chlorhexidine gluconate ethanol disinfection solution and production method as well as disinfection cotton swab and disinfection cotton piece |
CN104622716A (en) * | 2015-02-27 | 2015-05-20 | 李航 | Medical nursing wet tissue which is non-alcoholic, long-acting, antibacterial and capable of removing dirt and disinfectant |
US20150374729A1 (en) * | 2014-06-25 | 2015-12-31 | The Clorox Company | Disinfectant delivery system and method for disinfection |
-
2018
- 2018-12-25 CN CN201811589716.4A patent/CN111358769A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5690958A (en) * | 1996-09-30 | 1997-11-25 | Medi-Flex Hospital Products, Inc. | Unit dose chlorhexadine gluconate(CHG) applicator having extended CHG shelf life |
CN2327337Y (en) * | 1998-02-17 | 1999-07-07 | 赵清玲 | Disposable assembled box for sterilization and dressing change |
US20040230168A1 (en) * | 2003-05-12 | 2004-11-18 | Thomas Keaty | Disinfectant delivery system, and method of providing alcohol-free disinfection |
CN103704241A (en) * | 2013-12-23 | 2014-04-09 | 杭州美克恒辉实业有限公司 | Chlorhexidine gluconate ethanol disinfection solution and production method as well as disinfection cotton swab and disinfection cotton piece |
US20150374729A1 (en) * | 2014-06-25 | 2015-12-31 | The Clorox Company | Disinfectant delivery system and method for disinfection |
CN104622716A (en) * | 2015-02-27 | 2015-05-20 | 李航 | Medical nursing wet tissue which is non-alcoholic, long-acting, antibacterial and capable of removing dirt and disinfectant |
Non-Patent Citations (8)
Title |
---|
CHARLES E EDMISTON等: "Preadmission Application of 2% Chlorhexidine Gluconate (CHG): Enhancing Patient Compliance While Maximizing Skin Surface Concentrations", 《INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY》 * |
CHARLES E EDMISTON等: "Preadmission Application of 2% Chlorhexidine Gluconate (CHG): Enhancing Patient Compliance While Maximizing Skin Surface Concentrations", 《INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY》, vol. 37, no. 3, 28 December 2015 (2015-12-28), pages 254 - 259 * |
MICHAEL R MURRAY等,: "Efficacy of preoperative home use of 2% chlorhexidine gluconate cloth before shoulder surgery", 《JOURNAL OF SHOULDER AND ELBOW SURGERY》 * |
MICHAEL R MURRAY等,: "Efficacy of preoperative home use of 2% chlorhexidine gluconate cloth before shoulder surgery", 《JOURNAL OF SHOULDER AND ELBOW SURGERY》, vol. 20, no. 6, 30 September 2011 (2011-09-30), pages 928 - 933, XP028260294, DOI: 10.1016/j.jse.2011.02.018 * |
冯波等: "葡萄糖酸氯己定抗菌辅料联合氯己定擦浴在预防股静脉血滤导管相关血流感染中的效果研究", 《中国实用护理杂志》, vol. 34, no. 15, 21 May 2018 (2018-05-21), pages 1182 - 1185 * |
陈焕英等: "一次性医用消毒湿巾的皮肤消毒效果评价", 《中国消毒学杂志》 * |
陈焕英等: "一次性医用消毒湿巾的皮肤消毒效果评价", 《中国消毒学杂志》, vol. 34, no. 7, 15 July 2017 (2017-07-15), pages 622 - 624 * |
马建伟等主编: "《非织造布实用教程》", vol. 1994, 华中科技大学出版社, pages: 23 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11559503B2 (en) | Materials and methods for controlling infections | |
KR101725175B1 (en) | Antimicrobial composition | |
Lund et al. | Neonatal skin care: the scientific basis for practice | |
EP2811988B1 (en) | Adhesive patch with antimicrobial composition | |
Abdel-Sayed et al. | Implications of chlorhexidine use in burn units for wound healing | |
Popp et al. | Hospital-acquired infections and thermally injured patients: chlorhexidine gluconate baths work | |
CN101810639A (en) | Broad-spectrum touch-out medical bactericide and preparation method thereof | |
TWI735998B (en) | Antimicrobial kit and article | |
CN107349039A (en) | A kind of chest and abdomen used after operation safty shield | |
TWI683676B (en) | Antimicrobial kit and article | |
CN111358769A (en) | Antimicrobial kits and articles | |
Murie et al. | Chlorhexidine in methanol for the preoperative cleansing of surgeons' hands: a clinical trial | |
CN205758902U (en) | A kind of disposable tracheal tube cleaning and sterilizing nursing bag | |
RU72626U1 (en) | UNIVERSAL LAYING FOR THE ELIMINATION OF ACCIDENTS WHEN WORKING WITH ACTIVATORS OF DANGEROUS INFECTIOUS DISEASES | |
Liden et al. | Hypochlorous acid: Its multiple uses for wound care | |
Aldridge | How to carry out initial treatment of traumatic wounds: assessment, preparation and lavage | |
Watret et al. | Making sense of wound cleansing | |
CN215779222U (en) | Boric acid absorbent cotton nursing bag | |
Winston et al. | Preparation for surgery | |
CN209464257U (en) | Portable dressing change kit after circumcision | |
Wickramasinghe et al. | Health care associated infection (HCAI) | |
CN1644145A (en) | Wet nonwoven towel containing tannic acid | |
CN205433906U (en) | Disposable package of changing dressings | |
Romosan et al. | Professional and management issues in the survey and control of nosocomial infections in general surgery hospitals | |
CN103800363A (en) | Application of 5 percent sodium bicarbonate solution in dressing change of deep venous catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |